These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 17240623)

  • 21. High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk.
    Zhao H; Li H; Huang T
    Biol Trace Elem Res; 2018 Aug; 184(2):317-324. PubMed ID: 29164514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.
    Cherk MH; Francis P; Topliss DJ; Bailey M; Kalff V
    Clin Endocrinol (Oxf); 2012 May; 76(5):734-40. PubMed ID: 22050475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma.
    Farrag TY; Agrawal N; Sheth S; Bettegowda C; Ewertz M; Kim M; Tufano RP
    Head Neck; 2007 Dec; 29(12):1069-74. PubMed ID: 17563908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative serum thyroglobulin as an adjunct to fine-needle aspiration in predicting well-differentiated thyroid cancer.
    Sands NB; Karls S; Rivera J; Tamilia M; Hier MP; Black MJ; Gologan O; Payne RJ
    J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):669-73. PubMed ID: 21144363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
    Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
    [No Abstract]   [Full Text] [Related]  

  • 26. Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma.
    Lee JI; Chung YJ; Cho BY; Chong S; Seok JW; Park SJ
    Surgery; 2013 Jun; 153(6):828-35. PubMed ID: 23489940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid fine-needle aspiration biopsy: which lesions should be biopsied before 131I therapy?
    Listewnik MH; Birkenfeld B; Chosia M; Elbl B; Piwowarska-Bilska H; Zorga P; Niedziałkowska K
    Ann Acad Med Stetin; 2011; 57(1):54-8. PubMed ID: 22593992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
    Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative Serum Thyrotropin to Thyroglobulin Ratio Is Effective for Thyroid Nodule Evaluation in Euthyroid Patients.
    Wang L; Li H; Yang Z; Guo Z; Zhang Q
    Otolaryngol Head Neck Surg; 2015 Jul; 153(1):15-9. PubMed ID: 25883100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil to Lymphocyte Ratio is Useful in Differentiation of Malign and Benign Thyroid Nodules.
    Sit M; Aktas G; Erkol H; Yaman S; Keyif F; Savli H
    P R Health Sci J; 2019 Mar; 38(1):60-63. PubMed ID: 30924917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical profile and management of primary thyroid cancer in patients with nodular goitre at the Douala General Hospital, Cameroon.
    Linwa EMM; Ngom EM; Orock GEE; Ekoube CE; Linwa EEN; Budzi NM; Meh MG; Louis RN
    Pan Afr Med J; 2021; 38():405. PubMed ID: 34381549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer.
    Yaylaci S; Tosun O; Sahin O; Genc AB; Aydin E; Demiral G; Karahalil F; Olt S; Ergenc H; Varim C
    Asian Pac J Cancer Prev; 2016; 17(4):2321-3. PubMed ID: 27221938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic features of polycystic thyroid disease: comparison with benign nodular goiter.
    Kubota S; Hirokawa M; Takamura Y; Ito Y; Tamai H; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
    Endocr J; 2011; 58(9):783-8. PubMed ID: 21737959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Numbers of Circulating Tumor Cells in Thyroid Cancer Patients.
    Ehlers M; Allelein S; Schwarz F; Hautzel H; Kuebart A; Schmidt M; Haase M; Dringenberg T; Schott M
    Horm Metab Res; 2018 Aug; 50(8):602-608. PubMed ID: 30081408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of serum insulin-like growth factor 1 and its significance in thyroid cancer: An observational study.
    Hou YL; Chen JJ; Zhang X; Chen H
    Medicine (Baltimore); 2021 May; 100(21):e26165. PubMed ID: 34032777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
    Fatemi S; LoPresti JS
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4507-8; author reply 4508-10. PubMed ID: 12970333
    [No Abstract]   [Full Text] [Related]  

  • 37. [Thyroid carcinoma. A descriptive retrospective study].
    Gonzalez CC; Yaniskowski ML; Wyse EP; Giovannini AA; Lopez MB; Wior ME
    Medicina (B Aires); 2006; 66(6):526-32. PubMed ID: 17240623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
    Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
    Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
    Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
    Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
    Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
    Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.